ニュース

BioWorld19 時間
Urogen still rising on FDA go-ahead for bladder cancer drug Zusduri
Urogen Pharma Ltd. plans to launch its new product July 1 after the firm overcame a decidedly mixed FDA advisory panel meeting to nail down approval June 12 of Zusduri (mitomycin, formerly known as ...